Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.52 is 50% below its 5-year average of 7.09, near the low end of its 5-year range (3.52–13.46).
As of the fiscal period ended Tuesday, June 30, 2026. 14.73% below its 12-month average of 4.12.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.52.
QUICK RATIO (ACID-TEST)
3.52
QUICK RATIO (ACID-TEST) AVG TTM
4.12
QUICK RATIO (ACID-TEST) AVG 3Y
5.42
QUICK RATIO (ACID-TEST) AVG 5Y
7.09
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-14.73%
CURRENT VS 3Y AVG
-35.11%
CURRENT VS 5Y AVG
-50.43%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.16
median of 722 covered companies
CURRENT VS SECTOR MEDIAN
+11.44%
vs the sector median at left
Pulmonx Corporation
Market Cap
$79.83M
Quick Ratio (Acid-Test)
3.52
TTM Avg
4.12
3Y Avg
5.42
5Y Avg
7.09
Market Cap
$79.46M
Quick Ratio (Acid-Test)
1.00
TTM Avg
2.08
3Y Avg
2.75
5Y Avg
4.86
Market Cap
$81.38M
Quick Ratio (Acid-Test)
4.02
TTM Avg
5.44
3Y Avg
3.75
5Y Avg
3.66
Market Cap
$77.54M
Quick Ratio (Acid-Test)
0.14
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.07
Market Cap
$82.45M
Quick Ratio (Acid-Test)
8.75
TTM Avg
11.02
3Y Avg
14.04
5Y Avg
18.21
Market Cap
$83.04M
Quick Ratio (Acid-Test)
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
Market Cap
$83.48M
Quick Ratio (Acid-Test)
0.34
TTM Avg
0.10
3Y Avg
0.26
5Y Avg
0.26
Market Cap
$75.81M
Quick Ratio (Acid-Test)
5.45
TTM Avg
4.61
3Y Avg
8.17
5Y Avg
10.19
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | $79.83M | 3.52 | 4.12 | 5.42 | 7.09 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | 1.00 | 2.08 | 2.75 | 4.86 |
| Nutriband Inc. (NTRB)vs › | $81.38M | 4.02 | 5.44 | 3.75 | 3.66 |
| LENSAR Inc (LNSR)vs › | $82.53M | 1.13 | 1.33 | 1.81 | 2.82 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | 0.14 | 0.07 | 0.07 | 0.07 |
| MediciNova, Inc. (MNOV)vs › | $82.45M | 8.75 | 11.02 | 14.04 | 18.21 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | 7.99 | 9.12 | 12.06 | 14.25 |
| Citius Oncology, Inc. (CTOR)vs › | $83.48M | 0.34 | 0.10 | 0.26 | 0.26 |
| Hyperfine, Inc. (HYPR)vs › | $75.81M | 5.45 | 4.61 | 8.17 | 10.19 |
| Outset Medical, Inc. (OM)vs › | $76.35M | 4.11 | 4.89 | 5.09 | 6.08 |
Quick Ratio
3.52
Excludes inventory
Current Ratio
4.32
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.52 |
| 2026-03-31 | 4.04 |
| 2025-12-31 | 4.28 |
| 2025-09-30 | 4.15 |
| 2025-06-30 | 4.63 |
| 2025-03-31 | 4.29 |
| 2024-12-31 | 4.88 |
| 2024-09-30 | 6.77 |
| 2024-06-30 | 7.92 |
| 2024-03-31 | 6.14 |
| 2023-12-31 | 5.77 |
| 2023-09-30 | 6.41 |
| 2023-06-30 | 7.62 |
| 2023-03-31 | 9.70 |
| 2022-12-31 | 8.35 |
| 2022-09-30 | 7.73 |
| 2022-06-30 | 8.49 |
| 2022-03-31 | 10.30 |
| 2021-12-31 | 10.92 |
| 2021-09-30 | 9.57 |
| 2021-06-30 | 13.46 |
| 2021-03-31 | 16.22 |
| 2020-12-31 | 19.10 |
| 2020-09-30 | 3.05 |
| 2020-06-30 | 5.32 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.50 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
